ASSOCIATION OF HLA POLYMORPHISMS WITH EPSTEIN-BARR VIRUS INFECTION AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Lin, R. [1 ]
Fan, Q. [1 ]
Yu, S. [1 ]
Fan, Z. [1 ]
Zhang, Y. [1 ]
Huang, F. [1 ]
Zhou, H. [1 ]
Xuan, L. [1 ]
Wu, M.
Guo, X. [1 ]
Dai, M. [1 ]
Sun, J. [1 ]
Liu, Q. [1 ]
机构：
[1] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P894
引用
收藏
页码：372 / 372
页数：1
相关论文
共 50 条
  • [21] Subcutaneous administration of rituximab in patients with Epstein-Barr virus reactivation after allogeneic stem cell transplantation
    Klink, A.
    Schmidt, V.
    Dornaus, S.
    Winkelmann, N.
    Sayer, H. G.
    von Lilienfeld-Toal, M.
    Hochhaus, A.
    Hilgendod, I.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S191 - S191
  • [22] Epstein-Barr virus reactivation after allogeneic stem cell transplantation without lymph node enlargement
    Krüger, WH
    Schüler, F
    Lotze, C
    Schwesinger, G
    Mentel, R
    Busemann, C
    Dölken, G
    ANNALS OF HEMATOLOGY, 2005, 84 (07) : 477 - 478
  • [23] Epstein-Barr virus-associated posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation
    Sanz, Jaime
    Andreu, Rafael
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (06) : 677 - 683
  • [24] Rituximab in the Treatment of Epstein-Barr Virus Infection after hematopoietic stem cell Transplantation in Children
    Peng, Zhiyong
    Li, Chunfu
    He, Yuelin
    BLOOD, 2014, 124 (21)
  • [25] Epstein-Barr virus in paediatric stem cell transplantation
    Staehelin, F
    Beutler, D
    Avoledo, P
    Gratwohl, A
    Kühne, T
    BONE MARROW TRANSPLANTATION, 2004, 33 : S229 - S229
  • [26] Epstein-Barr virus driven lymphoproliferative disorders post allogeneic stem cell transplantation
    Lavin, M.
    Crowley, B.
    Browne, P. V.
    Flynn, C.
    Hayden, P.
    Vandenberghe, E.
    O'Neill, G.
    Conneally, E.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S143 - S143
  • [27] Pre-emptive treatment with rituximab for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation: a safety and efficacy study
    Ganguly, S.
    DuBois, L.
    Divine, C.
    Aljitawi, O.
    Abhyankar, S.
    McGuirk, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S225 - S225
  • [28] Active cytomegalovirus infection is not a risk factor for Epstein-Barr virus DNAemia in the allogeneic stem cell transplantation setting
    Gimenez, Estela
    Solano, Carlos
    Bravo, Dayana
    Amat, Paula
    Jose Remigia, Maria
    Alberola, Juan
    Navarro, David
    CLINICAL TRANSPLANTATION, 2014, 28 (04) : 508 - 509
  • [29] EPSTEIN-BARR VIRUS ASSOCIATED COMPLICATIONS AND THEIR ASSOCIATION WITH ANTITHYMOCYTE GLOBULIN IN PEDIATRIC ALLOGENEIC STEM-CELL TRANSPLANTATION
    Ali, M.
    Asim, M.
    Pole, J. D.
    Dupuis, L.
    Allen, U.
    Egeler, M.
    Al-Afghani, S.
    Stesco, N.
    Gassas, A.
    Doyle, J.
    Schechter, T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S310 - S310
  • [30] Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab
    Na Wei
    Yini Wang
    Jingshi Wang
    Lin Wu
    Zhao Wang
    Bone Marrow Transplantation, 2021, 56 : 1449 - 1451
12345